Association of T-cell reactivity with β-cell function in recent onset type 1 diabetes patients

Journal of Autoimmunity

Volumn 34, Issue 2, 2010, Pages 127-135

  Pfleger, Christian ^a   Meierhoff, Guido ^a   Kolb, Hubert ^a   Schloot, Nanette C ^a,b  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Cytokines; ELISPOT; IFN ; IL 10; Islet reactive T cells; Type 1 diabetes

Indexed keywords

ANTIDIABETIC AGENT; C PEPTIDE; DIAPEP 277; GAMMA INTERFERON; GLUCAGON; GLUTAMATE DECARBOXYLASE 65; INSULIN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; PLACEBO; PROTEIN TYROSINE PHOSPHATASE; TETANUS TOXOID; UNCLASSIFIED DRUG;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CELL FUNCTION; CELLULAR IMMUNITY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PANCREAS ISLET BETA CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE;

ADOLESCENT; ADULT; AUTOANTIGENS; C-PEPTIDE; CELLS, CULTURED; CHILD; CYTOKINES; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLUCAGON; HUMANS; INSULIN-SECRETING CELLS; MALE; T-CELL ANTIGEN RECEPTOR SPECIFICITY; TH1 CELLS; TH2 CELLS;

EID: 75349111902     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.08.004     Document Type: Article

References (34)

1. Roep B.O. The role of T-cells in the pathogenesis of type 1 diabetes: from cause to cure. Diabetologia 46 3 (2003) 305-321
2. Schloot N.C., Willemen S., Duinkerken G., de Vries R.R., and Roep B.O. Cloned T cells from a recent onset IDDM patient reactive with insulin B-chain. J Autoimmun 11 2 (1998) 169-175
3. Huurman V.A., van der Meide P.E., Duinkerken G., Willemen S., Cohen I.R., Elias D., et al. Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes. Clin Exp Immunol 152 3 (2008) 488-497
4. Meierhoff G., Ott P.A., Lehmann P.V., and Schloot N.C. Cytokine detection by ELISPOT: relevance for immunological studies in type 1 diabetes. Diabetes Metab Res Rev 18 5 (2002) 367-380
5. Schloot N.C., Meierhoff G., Karlsson F.M., Ott P., Putnam A., Lehmann P., et al. Comparison of cytokine ELISPOT assay formats for the detection of islet antigen autoreactive T cells. Report of the third immunology of diabetes society T-cell workshop. J Autoimmun 21 4 (2003) 365-376
6. Herzog B.A., Ott P.A., Dittrich M.T., Quast S., Karulin A.Y., Kalbacher H., et al. Increased in vivo frequency of IA-2 peptide-reactive IFNgamma+/IL-4- T cells in type 1 diabetic subjects. J Autoimmun 23 1 (2004) 45-54
7. Ott P.A., Herzog B.A., Quast S., Hofstetter H.H., Boehm B.O., Tary-Lehmann M., et al. Islet-cell antigen-reactive T cells show different expansion rates and Th1/Th2 differentiation in type 1 diabetic patients and healthy controls. Clin Immunol 115 1 (2005) 102-114
8. Arif S., Tree T.I., Astill T.P., Tremble J.M., Bishop A.J., Dayan C.M., et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 113 3 (2004) 451-463
9. Stechova K., Bohmova K., Vrabelova Z., Sepa A., Stadlerova G., Zacharovova K., et al. High T-helper-1 cytokines but low T-helper-3 cytokines, inflammatory cytokines and chemokines in children with high risk of developing type 1 diabetes. Diabetes Metab Res Rev 23 6 (2007) 462-471
10. Sanda S., Roep B.O., and von Herrath M. Islet antigen specific IL-10(+) immune responses but not CD4(+)CD25(+)FoxP3(+) cells at diagnosis predict glycemic control in type 1 diabetes. Clin Immunol 127 2 (2008) 138-143
11. Pfleger C., Mortensen H.B., Hansen L., Herder C., Roep B.O., Hoey H., et al. Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes. Diabetes 57 4 (2008) 929-937
12. Pfleger C., Kaas A., Hansen L., Alizadeh B., Hougaard P., Holl R., et al. Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes. Clin Immunol 128 1 (2008) 57-65
13. Schloot N.C., Meierhoff G., Lengyel C., Vandorfi G., Takacs J., Panczel P., et al. Effect of heat shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: two prospective, randomized, double-blind phase II trials. Diabetes Metab Res Rev 23 4 (2007) 276-285
14. Petrone A., Galgani A., Spoletini M., Alemanno I., Di Cola S., Bassotti G., et al. Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype. Diabetes Metab Res Rev 21 3 (2005) 271-275
15. Nagata M., Kotani R., Moriyama H., Yokono K., Roep B.O., and Peakman M. Detection of autoreactive T cells in type 1 diabetes using coded autoantigens and an immunoglobulin-free cytokine ELISPOT assay: report from the fourth immunology of diabetes society T cell workshop. Ann N Y Acad Sci 1037 (2004) 10-15
16. Hawkes C.J., Schloot N.C., Marks J., Willemen S.J., Drijfhout J.W., Mayer E.K., et al. T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes. Diabetes 49 3 (2000) 356-366
17. Habich C., Baumgart K., Kolb H., and Burkart V. The receptor for heat shock protein 60 on macrophages is saturable, specific, and distinct from receptors for other heat shock proteins. J Immunol 168 2 (2002) 569-576
18. Herder C., Schneitler S., Rathmann W., Haastert B., Schneitler H., Winkler H., et al. Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab 92 12 (2007) 4569-4574
19. Herder C., Baumert J., Thorand B., Koenig W., de Jager W., Meisinger C., et al. Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002. Diabetologia 49 5 (2006) 921-929
20. Llewelyn M., Sriskandan S., Peakman M., Ambrozak D.R., Douek D.C., Kwok W.W., et al. HLA class II polymorphisms determine responses to bacterial superantigens. J Immunol 172 3 (2004) 1719-1726
21. Reis E.A., Athanazio D.A., McBride A.J., Azevedo T.M., Magalhaes-Santos I.F., Harn D., et al. Influence of the HLA-DQB1*0201 allele on the immune response in a Schistosoma mansoni infection. Acta Trop (2008)
22. Higai K., Tsukada M., Moriya Y., Azuma Y., and Matsumoto K. Prolonged high glucose suppresses phorbol 12-myristate 13-acetate and ionomycin-induced interleukin-2 mRNA expression in jurkat cells. Biochim Biophys Acta 1790 1 (2009) 8-15
23. Otto N.M., Schindler R., Lun A., Boenisch O., Frei U., and Oppert M. Hyperosmotic stress enhances cytokine production and decreases phagocytosis in vitro. Crit Care 12 4 (2008) R107
24. Rubinstein R., Genaro A.M., Motta A., Cremaschi G., and Wald M.R. Impaired immune responses in streptozotocin-induced type I diabetes in mice. Involvement of high glucose. Clin Exp Immunol 154 2 (2008) 235-246
25. Stegenga M.E., van der Crabben S.N., Dessing M.C., Pater J.M., van den Pangaart P.S., de Vos A.F., et al. Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabet Med 25 2 (2008) 157-164
26. Martinuzzi E., Novelli G., Scotto M., Blancou P., Bach J.M., Chaillous L., et al. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment. Diabetes 57 5 (2008) 1312-1320
27. Ruber M., Berg A., Ekerfelt C., Olaison G., and Andersson R.E. Different cytokine profiles in patients with a history of gangrenous or phlegmonous appendicitis. Clin Exp Immunol 143 1 (2006) 117-124
28. Faresjo M.K., Vaarala O., Thuswaldner S., Ilonen J., Hinkkanen A., and Ludvigsson J. Diminished IFN-gamma response to diabetes-associated autoantigens in children at diagnosis and during follow up of type 1 diabetes. Diabetes Metab Res Rev 22 6 (2006) 462-470
29. Marttila J., Huttunen S., Vaarala O., Suzuki K., Elliott J.F., Narvanen A., et al. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies. J Autoimmun 31 2 (2008) 142-148
30. Baschal E.E., and Eisenbarth G.S. Extreme genetic risk for type 1A diabetes in the post-genome era. J Autoimmun 31 1 (2008) 1-6
31. Yang J., Danke N., Roti M., Huston L., Greenbaum C., Pihoker C., et al. CD4+ T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope. J Autoimmun 31 1 (2008) 30-41
32. Weenink S.M., Lo J., Stephenson C.R., McKinney P.A., Ananieva-Jordanova R., Rees S.B., et al. Autoantibodies and associated T-cell responses to determinants within the 831-860 region of the autoantigen IA-2 in type 1 diabetes. J Autoimmun (2009)
33. Marino E., and Grey S.T. A new role for an old player: do B cells unleash the self-reactive CD8+ T cell storm necessary for the development of type 1 diabetes?. J Autoimmun 31 3 (2008) 301-305
34. Harrison L.C., Honeyman M.C., Morahan G., Wentworth J.M., Elkassaby S., Colman P.G., et al. Type 1 diabetes: lessons for other autoimmune diseases?. J Autoimmun 31 3 (2008) 306-310